Exploring anti-IL6 receptor monoclonal antibody tocilizumab in neuromyelitis optica

被引：0
|
作者：
Araki, M. [1 ]
Matsuoka, T. [1 ]
Aranami, T. [1 ]
Nakamura, M. [1 ]
Okamoto, T. [1 ]
Murata, M. [1 ]
Miyake, S. [1 ]
Yamamura, T. [1 ]
机构：
[1] Natl Ctr Neurol & Psychiat, Tokyo, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：326 / 327
页数：2
相关论文
共 50 条
  • [41] Monoclonal antibody therapy for neuromyelitis optica spectrum disorder: current and future
    Lin, Jie
    Xue, Binbin
    Li, Xiang
    Xia, Junhui
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2017, 127 (08) : 735 - 744
  • [42] A double-blind placebo-controlled study of satralizumab (SA237), a recycling anti-IL-6 receptor monoclonal antibody, as monotherapy for patients with neuromyelitis optica spectrum disorder (NMOSD)
    Traboulsee, A.
    Greenberg, B.
    Bennett, J. L.
    Szczechowski, L.
    Fox, E.
    Shkrobot, S.
    Yamamura, T.
    Terada, Y.
    Kawata, Y.
    Melia, A.
    Gianella-Borradori, A.
    Weinshenker, B. G.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 730 - 731
  • [43] Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis
    Marco Zoccarato
    Maria Valeria Saddi
    Giulia Serra
    Maria Federica Pelizza
    Irene Rosellini
    Luigi Peddone
    Anna Ticca
    Bruno Giometto
    Luigi Zuliani
    Journal of Neurology, 2013, 260 : 3185 - 3187
  • [44] Efficacy and Safety of Anti-Interleukin 6 Receptor Monoclonal Antibody (Tocilizumab) in Colombian Patients With Takayasu Arteritis
    Alberto Canas, Carlos
    Canas, Felipe
    Hernan Izquierdo, Jorge
    Echeverri, Andres-Felipe
    Mejia, Mauricio
    Bonilla-Abadia, Fabio
    Tobon, Gabriel J.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2014, 20 (03) : 125 - 129
  • [45] Tocilizumab (humanized anti IL-6 receptor monoclonal antibody) in patients with systemic lupus erythematosus (SLE): Safety, tolerability and preliminary efficacy.
    Illei, Gabor G.
    Yarboro, Cheryl
    Shirota, Yuko
    Tackey, Edward
    Lapteva, Larissa
    Fleisher, Thomas
    Balow, James
    Lipsky, Peter
    ARTHRITIS AND RHEUMATISM, 2006, 54 (12): : 4043 - 4043
  • [46] Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis
    Zoccarato, Marco
    Saddi, Maria Valeria
    Serra, Giulia
    Pelizza, Maria Federica
    Rosellini, Irene
    Peddone, Luigi
    Ticca, Anna
    Giometto, Bruno
    Zuliani, Luigi
    JOURNAL OF NEUROLOGY, 2013, 260 (12) : 3185 - 3187
  • [47] Endogenous interleukin 6 production in multiple myeloma patients treated with chimeric monoclonal anti-IL6 antibodies
    vanZaanen, HCT
    Koopmans, RP
    Aarden, LA
    Rensink, HJAM
    Stouthard, JML
    Warnaar, SO
    Lokhorst, HM
    vanOers, MHJ
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 618 - 618
  • [48] Targeting the IL-6 receptor with the monoclonal antibody tocilizumab significantly improves quality of life in patients with rheumatoid arthritis
    Smolen, J.
    Atkins, C.
    Rovensky, J.
    Ramos-Remus, C.
    Lucero, M.
    Woodworth, T.
    Alten, R.
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (06) : 1181 - 1182
  • [49] The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab
    Shima, Yoshihito
    Kuwahara, Yusuke
    Murota, Hiroyuki
    Kitaba, Shun
    Kawai, Mari
    Hirano, Toru
    Arimitsu, Junsuke
    Narazaki, Masashi
    Hagihara, Keisuke
    Ogata, Atsushi
    Katayama, Ichiro
    Kawase, Ichiro
    Kishimoto, Tadamitsu
    Tanaka, Toshio
    RHEUMATOLOGY, 2010, 49 (12) : 2408 - 2412
  • [50] The recombinant humanized anti-IL-6 receptor antibody tocilizumab, an innovative drug for the treatment of rheumatoid arthritis
    Ohsugi, Yoshiyuki
    Kishimoto, Tadamitsu
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (05) : 669 - 681
12345